Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The treatment successfully lowered testosterone levels and reduced symptoms.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Mirtazapine can cause male breast enlargement.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Cimetidine does not significantly reduce hair growth in hirsutism.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.